Trial Design Milestones
10.A-10.H
No filters selected
ID
Title
Status
10.A
Trial Design: Interpretation of trial data
Convene a meeting that brings together epidemiologists, clinical trialists, clinical practitioners, representatives from industry and patient advocates from diverse communities to formulate guidelines...
Status
In Progress
10.B
Trial Design: Standard outcome measures
Establish a working group to identify standard outcome measures necessary for data comparisons across secondary prevention trials...
Status
Achieved
10.C
Trial Design: Studies using common standard outcome measures
Initiate 3-4 clinical research studies using common standard outcome measures...
Status
Achieved
10.D
Trial Design: Precision medicine
Create new research programs to implement innovative trial designs with a precision medicine research paradigm.
Status
In Progress
10.E
Trial Design: Dissemination methodologies
Support research on the effectiveness of dissemination methodologies to facilitate the implementation of effective prevention strategies.
Status
To Be Initiated
10.F
Trial Design: Experimental medicine approach to primary prevention
Convene an advisory meeting to evaluate how assays and best practices developed in the context of the NIH Common Fund Science of Behavior Change...
Status
Achieved
10.G
Health Equity: Optimize vascular health trial design for diverse populations
Enrich the design of trials of vascular health interventions to improve their application to AD/ADRD among aging diverse populations.
Status
In Progress
10.H
Health Equity: Design culturally tailored interventions
Implement culturally tailored multimodal intervention trials and drug therapy trials reduce AD/ADRD burden
Status
Achieved